Durand D - Search Results

1

Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D, Suc JM. Rostaing L, et al. Among authors: durand d. Nephrol Dial Transplant. 1995;10 Suppl 6:93-6. doi: 10.1093/ndt/10.supp6.93. Nephrol Dial Transplant. 1995. PMID: 8524507 Clinical Trial.

2

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Kamar N, Sandres-Saune K, Selves J, Ribes D, Cointault O, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. Am J Kidney Dis. 2003 Jul;42(1):184-92. doi: 10.1016/s0272-6386(03)00422-0. Am J Kidney Dis. 2003. PMID: 12830471 Clinical Trial.

3

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. Among authors: durand d. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

4

Amantadine therapy in renal transplant patients with hepatitis C virus infection.

Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J. Kamar N, et al. Among authors: durand d. J Clin Virol. 2004 May;30(1):110-4. doi: 10.1016/j.jcv.2003.10.001. J Clin Virol. 2004. PMID: 15072764 Clinical Trial.

5

Effects of long-term lamivudine therapy in renal-transplant patients.

Kamar N, Sandres-Saune K, Ribes D, Duffaut M, Selves J, Durand D, Izopet J, Rostaing L. Kamar N, et al. Among authors: durand d. J Clin Virol. 2004 Dec;31(4):298-303. doi: 10.1016/j.jcv.2004.07.001. J Clin Virol. 2004. PMID: 15494273

6

Course of hemophagocytic histiocytic syndrome in renal transplant patients.

Rostaing L, Fillola G, Baron E, Cisterne JM, Durand D. Rostaing L, et al. Among authors: durand d. Transplantation. 1995 Sep 15;60(5):506-9. doi: 10.1097/00007890-199509000-00018. Transplantation. 1995. PMID: 7676502 No abstract available.

7

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Rostaing L, et al. Among authors: durand d. Transplantation. 1995 May 27;59(10):1426-31. doi: 10.1097/00007890-199505270-00012. Transplantation. 1995. PMID: 7770930 Clinical Trial.

8

Renal oncocytoma in transplant patients: report of 2 cases.

Rostaing L, Escourrou G, Mazerolles C, Durand D, Lloveras JJ, Suc JM. Rostaing L, et al. Among authors: durand d. Nephron. 1994;68(3):375-7. doi: 10.1159/000188403. Nephron. 1994. PMID: 7838263

9

Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Rostaing L, et al. Among authors: durand d. Transplant Proc. 1995 Feb;27(1):948-50. Transplant Proc. 1995. PMID: 7879242 Clinical Trial. No abstract available.

10

Successful treatment of post-renal transplant erythrocytosis with enalapril.

Rostaing L, Boisseau M, Durand D, Huyn A, Lloveras JJ, Suc JM. Rostaing L, et al. Among authors: durand d. Transplant Proc. 1993 Jun;25(3):2325-6. Transplant Proc. 1993. PMID: 8516915 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,213 results

Search Page

Filters